Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond

Publisher： John Wiley & Sons Inc

E-ISSN： 1757-7012|6|5|471-499

ISSN： 1757-7004

Source： WILEY INTERDISCIPLINARY REVIEWS: RNA (ELECTRONIC), Vol.6, Iss.5, 2015-09, pp. : 471-499

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Concise Review: Human Pluripotent Stem Cells to Produce Cell‐Based Cancer Immunotherapy

By  

STEM CELLS, Vol. 36, Iss. 2, 2018-02 ,pp. : 134-145

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical‐scale purification of pluripotent stem cell derivatives for cell‐based therapies

By  

BIOTECHNOLOGY JOURNAL (ELECTRONIC), Vol. 10, Iss. 8, 2015-08 ,pp. : 1103-1114

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury

By Doulames Vanessa M.   Plant Giles W.  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 530-530

MDPI

Access to resources Recommend Favorite

Application of biomaterials to advance induced pluripotent stem cell research and therapy

By  

THE EMBO JOURNAL, Vol. 34, Iss. 8, 2015-04 ,pp. : 987-1008

John Wiley & Sons Inc

Access to resources Recommend Favorite

Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy

By Chen Man   Yu Yuanyuan   Jiang Feng   Zhou Junwei   Li Yongshu   Liang Chao   Dang Lei   Lu Aiping   Zhang Ge  

International Journal of Molecular Sciences, Vol. 17, Iss. 12, 2016-12 ,pp. : 2079-2079

MDPI

Access to resources Recommend Favorite